These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 37379806
1. The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants. Warmerdam LA, van Wezel-Meijler G, de Vries LS, Groenendaal F, Steggerda SJ. Neonatology; 2023; 120(5):615-623. PubMed ID: 37379806 [Abstract] [Full Text] [Related]
2. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL. Cochrane Database Syst Rev; 2017 Oct 24; 10(10):CD001146. PubMed ID: 29063585 [Abstract] [Full Text] [Related]
3. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Halliday HL, Ehrenkranz RA, Doyle LW. Cochrane Database Syst Rev; 2010 Jan 20; (1):CD001146. PubMed ID: 20091516 [Abstract] [Full Text] [Related]
4. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Halliday HL, Ehrenkranz RA, Doyle LW. Cochrane Database Syst Rev; 2009 Jan 21; (1):CD001146. PubMed ID: 19160190 [Abstract] [Full Text] [Related]
5. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Doyle LW, Ehrenkranz RA, Halliday HL. Cochrane Database Syst Rev; 2014 May 13; (5):CD001146. PubMed ID: 24825456 [Abstract] [Full Text] [Related]
6. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL. Cochrane Database Syst Rev; 2017 Oct 24; 10(10):CD001145. PubMed ID: 29063594 [Abstract] [Full Text] [Related]
7. [Glucocorticoide therapy in premature infants: French practices in 2006]. Autret-Leca E, Bauer S, Alberti C, Jonville-Béra AP, Aujard Y, Bensouda-Grimaldi L, Baud O. Arch Pediatr; 2009 Jul 24; 16(7):999-1004. PubMed ID: 19410441 [Abstract] [Full Text] [Related]
8. Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants. Kersbergen KJ, de Vries LS, van Kooij BJ, Išgum I, Rademaker KJ, van Bel F, Hüppi PS, Dubois J, Groenendaal F, Benders MJ. J Pediatr; 2013 Sep 24; 163(3):666-71.e1. PubMed ID: 23706359 [Abstract] [Full Text] [Related]
9. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Halliday HL, Ehrenkranz RA, Doyle LW. Cochrane Database Syst Rev; 2009 Jan 21; (1):CD001145. PubMed ID: 19160189 [Abstract] [Full Text] [Related]
10. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial. Onland W, Cools F, Kroon A, Rademaker K, Merkus MP, Dijk PH, van Straaten HL, Te Pas AB, Mohns T, Bruneel E, van Heijst AF, Kramer BW, Debeer A, Zonnenberg I, Marechal Y, Blom H, Plaskie K, Offringa M, van Kaam AH, STOP-BPD Study Group. JAMA; 2019 Jan 29; 321(4):354-363. PubMed ID: 30694322 [Abstract] [Full Text] [Related]
11. Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial. He Y, Zhang Y, Gao S, Wang X, He N, Zhang D, Dong W, Wieg C, Lei X. Trials; 2020 Sep 03; 21(1):762. PubMed ID: 32883333 [Abstract] [Full Text] [Related]
12. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations]. Jarreau PH, Fayon M, Baud O, Autret-Leca E, Danan M, de Verdelhan A, Castot A. Arch Pediatr; 2010 Oct 03; 17(10):1480-7. PubMed ID: 20864322 [Abstract] [Full Text] [Related]
13. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Doyle LW, Ehrenkranz RA, Halliday HL. Cochrane Database Syst Rev; 2014 May 13; (5):CD001145. PubMed ID: 24825542 [Abstract] [Full Text] [Related]
14. The effect of postnatal corticosteroids on growth parameters in infants with bronchopulmonary dysplasia. Williams EE, Dassios T, Mann M, Greenough A. J Perinat Med; 2021 Nov 25; 49(9):1141-1144. PubMed ID: 34087969 [Abstract] [Full Text] [Related]
15. Neurodevelopment at 24 months corrected age in extremely preterm infants treated with dexamethasone alternatives during the late postnatal period: a cohort study. Melan N, Pradat P, Godbert I, Pastor-Diez B, Basson E, Picaud JC. Eur J Pediatr; 2024 Feb 25; 183(2):677-687. PubMed ID: 37955745 [Abstract] [Full Text] [Related]
16. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants. Hitzert MM, Benders MJ, Roescher AM, van Bel F, de Vries LS, Bos AF. Pediatr Res; 2012 Jan 25; 71(1):100-6. PubMed ID: 22289857 [Abstract] [Full Text] [Related]
17. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Onland W, Offringa M, van Kaam A. Cochrane Database Syst Rev; 2017 Aug 24; 8(8):CD002311. PubMed ID: 28836266 [Abstract] [Full Text] [Related]
18. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates. Shah SS, Ohlsson A, Halliday HL, Shah VS. Cochrane Database Syst Rev; 2017 Oct 17; 10(10):CD002058. PubMed ID: 29041034 [Abstract] [Full Text] [Related]
19. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Halliday HL, Ehrenkranz RA, Doyle LW. Cochrane Database Syst Rev; 2003 Oct 17; (1):CD001146. PubMed ID: 12535402 [Abstract] [Full Text] [Related]
20. Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis. Morris IP, Goel N, Chakraborty M. Eur J Pediatr; 2019 Aug 17; 178(8):1171-1184. PubMed ID: 31144162 [Abstract] [Full Text] [Related] Page: [Next] [New Search]